Skip to main content
. 2022 Apr 11;149(6):1949–1957. doi: 10.1016/j.jaci.2022.04.002

Fig 3.

Fig 3

SARS-CoV-2–specific neutralizing antibodies. A, Comparison of neutralizing antibodies (GMT ± 95% CI) determined by pseudovirus neutralization test after vaccination 2 between groups. LLoD is a 10 IU/mL. B, Comparison of neutralizing antibodies (GMT ± 95% CI) determined by PRNT after vaccination 2 between groups. LLoD is 14.29 IU/mL, and responder (resp) cutoff is 28.57 IU/mL (black dotted line). Number of participants above responder cutoff is indicated beneath the x-axis. Patients with IgG deficiencies and patients with SPAD are combined, but the original color coding (Fig 2, A) is maintained. LLoD, Lower level of detection; PRNT, plaque reduction neutralization test; VNT, virus neutralisation test.